4.5 Article

Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication

Journal

JOURNAL OF RHEUMATOLOGY
Volume 48, Issue 7, Pages 1047-1052

Publisher

J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.201005

Keywords

cardiomyopathies; heart disease; incidence; scleroderma; systemic sclerosis; valvular heart disease

Categories

Funding

  1. National Institute on Aging of the National Institutes of Health (NIH) [R01AG034676]
  2. National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]
  3. Mayo Clinic CTSA from the NCATS [UL1 TR002377]
  4. Department of Rheumatology and Clinical Immunology, University of Bern, Switzerland

Ask authors/readers for more resources

Patients with systemic sclerosis have a nearly 4-fold increased prevalence of moderate/severe valvular heart disease at diagnosis compared to non-SSc patients. They also have a 4-fold increased risk of developing moderate/severe valvular heart disease after diagnosis of SSc. Coronary artery disease is the only significant risk factor for valvular heart disease in these patients.
Objective. Cardiac involvement is a poor prognostic marker in systemic sclerosis (SSc). While diastolic dysfunction, myocardial fibrosis, and arrhythmias are traditionally considered features of primary cardiac involvement in SSc, the incidence of valvular heart disease (VHD) is not well reported. Our objective was to examine the prevalence of VHD at the time of SSc diagnosis and incidence of VHD during follow-up compared to non-SSc subjects. Methods. Medical records of patients with suspicion of SSc were reviewed to identify incident cases. SSc subjects were matched 1:2 by age and sex to non-SSc subjects. Results. The study included 78 incident SSc cases and 156 non-SSc comparators (56 yrs [+/- 15.7], 91% female). A nearly 4-fold increase in the prevalence of moderate/severe VHD prior to SSc diagnosis compared to non-SSc subjects (6% vs 0%; P = 0.004) was identified. During follow-up, 18 SSc and 12 non-SSc patients developed moderate/severe VHD. The cumulative incidence of VHD at 10 years after SSc incidence/index was 17.9% (95% CI 10.7-29.9) in patients with SSc compared with 2.3% (95% CI 0.7-7.0) in non- SSc subjects (HR 4.23, 95% CI 2.03-8.83). Coronary artery disease was the only significant risk factor for VHD. Conclusion. Patients with SSc have a 4-fold increase in the prevalence of moderate/severe VHD at diagnosis compared to non-SSc patients. They also have a 4-fold increased risk of developing moderate/severe VHD after diagnosis of SSc. Aortic stenosis and mitral regurgitation have a much higher prevalence in patients with SSc, besides secondary tricuspid regurgitation. Underlying mechanisms for this association require further elucidation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available